Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Neurocognitive development in perinatally HIV-infected adolescents on long-term treatment compared to healthy matched controls: a longitudinal study.

Van den Hof M, Ter Haar AM, Scherpbier HJ, van der Lee JH, Reiss P, Wit FWNM, Oostrom KJ, Pajkrt D.

Clin Infect Dis. 2019 May 18. pii: ciz386. doi: 10.1093/cid/ciz386. [Epub ahead of print]

PMID:
31106812
2.

Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Mulder RL, Bresters D, Van den Hof M, Koot BG, Castellino SM, Loke YKK, Post PN, Postma A, Szőnyi LP, Levitt GA, Bardi E, Skinner R, van Dalen EC.

Cochrane Database Syst Rev. 2019 Apr 15;4:CD008205. doi: 10.1002/14651858.CD008205.pub3.

PMID:
30985922
3.

No 375 - Directive clinique sur l'utilisation de l'échographie au premier trimestre.

Van den Hof MC, Smithies M, Nevo O, Ouellet A.

J Obstet Gynaecol Can. 2019 Mar;41(3):396-404. doi: 10.1016/j.jogc.2018.12.002.

PMID:
30784570
4.

No. 375-Clinical Practice Guideline on the Use of First Trimester Ultrasound.

Van den Hof MC, Smithies M, Nevo O, Oullet A.

J Obstet Gynaecol Can. 2019 Mar;41(3):388-395. doi: 10.1016/j.jogc.2018.09.020.

PMID:
30784569
5.

No 304 - Déclaration de principe commune SOGC/CAR sur l'utilisation non médicale de l'échographie fœtale.

Salem S, Lim K, Van den Hof MC.

J Obstet Gynaecol Can. 2019 Feb;41(2):e4-e6. doi: 10.1016/j.jogc.2018.11.023. No abstract available.

PMID:
30638561
6.

No. 304-Joint SOGC/CAR Policy Statement on Non-medical Use of Fetal Ultrasound.

Salem S, Lim K, Van den Hof MC.

J Obstet Gynaecol Can. 2019 Feb;41(2):e1-e3. doi: 10.1016/j.jogc.2018.11.022. No abstract available.

PMID:
30638559
7.

Predictors for surgical intervention and surgical outcomes in neonates with cystic fibrosis.

Jessula S, Van Den Hof M, Mateos-Corral D, Mills J, Davies D, Romao RL.

J Pediatr Surg. 2018 Nov;53(11):2150-2154. doi: 10.1016/j.jpedsurg.2018.05.016. Epub 2018 May 23.

PMID:
29941358
8.

No 359-Effets biologiques et innocuité de l'échographie obstétricale.

Van den Hof MC.

J Obstet Gynaecol Can. 2018 May;40(5):633-639. doi: 10.1016/j.jogc.2018.04.008. No abstract available. Erratum in: J Obstet Gynaecol Can. 2018 Dec;40(12):1703.

PMID:
29731209
9.

No. 359-Obstetric Ultrasound Biological Effects and Safety.

Van den Hof MC.

J Obstet Gynaecol Can. 2018 May;40(5):627-632. doi: 10.1016/j.jogc.2017.11.023. Erratum in: J Obstet Gynaecol Can. 2018 Dec;40(12):1702.

PMID:
29731208
10.

CNS penetration of ART in HIV-infected children.

Van den Hof M, Blokhuis C, Cohen S, Scherpbier HJ, Wit FWNM, Pistorius MCM, Kootstra NA, Teunissen CE, Mathot RAA, Pajkrt D.

J Antimicrob Chemother. 2018 Feb 1;73(2):484-489. doi: 10.1093/jac/dkx396.

PMID:
29126299
11.

No 192-Détermination et divulgation du sexe fœtal-Déclaration de principe.

Van den Hof MC, Demancziuk N.

J Obstet Gynaecol Can. 2017 Jul;39(7):e67-e68. doi: 10.1016/j.jogc.2017.04.012. French. No abstract available.

PMID:
28625295
12.

No. 192-Fetal Sex Determination and Disclosure Policy Statement.

Van den Hof MC, Demancziuk N.

J Obstet Gynaecol Can. 2017 Jul;39(7):e65-e66. doi: 10.1016/j.jogc.2017.04.011. No abstract available.

PMID:
28625294
13.

Déclaration de principe commune SOGC/CAR sur l'utilisation non médicale de l'échographie fœtal.

Salem S, Lim K, Van den Hof MC.

J Obstet Gynaecol Can. 2016 Dec;38(12S):S404-S406. doi: 10.1016/j.jogc.2016.09.049. Epub 2017 Jan 4. No abstract available.

PMID:
28063551
14.

Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes.

Liu S, Joseph KS, Luo W, León JA, Lisonkova S, Van den Hof M, Evans J, Lim K, Little J, Sauve R, Kramer MS; Canadian Perinatal Surveillance System (Public Health Agency of Canada).

Circulation. 2016 Aug 30;134(9):647-55. doi: 10.1161/CIRCULATIONAHA.116.022126.

15.

Severe laryngeal stenosis in newly born twins with 22q11.2 deletion syndrome: A case report.

Clive B, Corsten G, Penney LS, Van den Hof M, El-Naggar W.

J Neonatal Perinatal Med. 2016 May 18;9(2):223-6. doi: 10.3233/NPM-16915068.

PMID:
27197926
16.

A Woman With Marfan Syndrome in Pregnancy: Managing High Vascular Risk With Multidisciplinary Care.

Naud K, Horne G, Van den Hof M.

J Obstet Gynaecol Can. 2015 Aug;37(8):724-727. doi: 10.1016/S1701-2163(15)30177-8.

PMID:
26474229
17.

Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.

Wilson RD; Genetics Committee, Wilson RD, Audibert F, Brock JA, Carroll J, Cartier L, Gagnon A, Johnson JA, Langlois S, Murphy-Kaulbeck L, Okun N, Pastuck M; Special Contributors, Deb-Rinker P, Dodds L, Leon JA, Lowel HL, Luo W, MacFarlane A, McMillan R, Moore A, Mundle W, O'Connor D, Ray J, Van den Hof M.

J Obstet Gynaecol Can. 2015 Jun;37(6):534-52. English, French.

PMID:
26334606
18.

Twin-twin transfusion syndrome . . . or is it?

Coolen J, Van den Hof M.

J Obstet Gynaecol Can. 2014 Apr;36(4):289. doi: 10.1016/S1701-2163(15)30600-9. English, French. No abstract available.

PMID:
24798664
19.

Joint SOGC/CAR policy statement on non-medical use of fetal ultrasound.

Salem S, Lim K, Van den Hof MC; SOGC DIAGNOSTIC IMAGING COMMITTEE.

J Obstet Gynaecol Can. 2014 Feb;36(2):184-185. doi: 10.1016/S1701-2163(15)30666-6. English, French. No abstract available. Erratum in: J Obstet Gynaecol Can. 2014 Apr;36(4):295.

PMID:
24518918
20.

Association between maternal chronic conditions and congenital heart defects: a population-based cohort study.

Liu S, Joseph KS, Lisonkova S, Rouleau J, Van den Hof M, Sauve R, Kramer MS; Canadian Perinatal Surveillance System (Public Health Agency of Canada).

Circulation. 2013 Aug 6;128(6):583-9. doi: 10.1161/CIRCULATIONAHA.112.001054. Epub 2013 Jun 28.

PMID:
23812182
21.

Mobile remote-presence devices for point-of-care health care delivery.

Mendez I, Van den Hof MC.

CMAJ. 2013 Nov 19;185(17):1512-6. doi: 10.1503/cmaj.120223. Epub 2013 Jun 17. Review. No abstract available.

22.

Multivalent immune complexes divert FcRn to lysosomes by exclusion from recycling sorting tubules.

Weflen AW, Baier N, Tang QJ, Van den Hof M, Blumberg RS, Lencer WI, Massol RH.

Mol Biol Cell. 2013 Aug;24(15):2398-405. doi: 10.1091/mbc.E13-04-0174. Epub 2013 Jun 5.

23.

Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Mulder RL, van Dalen EC, Van den Hof M, Bresters D, Koot BG, Castellino SM, Loke Y, Leclercq E, Post PN, Caron HN, Postma A, Kremer LC.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008205. doi: 10.1002/14651858.CD008205.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Apr 15;4:CD008205.

24.

Peripartum factors predicting the need for increased doses of postpartum rhesus immune globulin.

Leyenaar L, Allen VM, Robinson HE, Parsons M, Van den Hof MC.

J Obstet Gynaecol Can. 2010 Aug;32(8):739-44.

PMID:
21050504
25.

Single umbilical artery risk factors and pregnancy outcomes.

Murphy-Kaulbeck L, Dodds L, Joseph KS, Van den Hof M.

Obstet Gynecol. 2010 Oct;116(4):843-50. doi: 10.1097/AOG.0b013e3181f0bc08.

PMID:
20859147
26.

Spina bifida before and after folic acid fortification in Canada.

De Wals P, Tairou F, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, Crowley M, Uh SH, Zimmer P, Sibbald B, Fernandez B, Lee NS, Niyonsenga T.

Birth Defects Res A Clin Mol Teratol. 2008 Sep;82(9):622-6. doi: 10.1002/bdra.20485.

PMID:
18655127
27.

Impact of folic acid food fortification on the birth prevalence of lipomyelomeningocele in Canada.

De Wals P, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, Crowley M, Tairou F, Uh SH, Sibbald B, Zimmer P, Fernandez B, Lee NS, Niyonsenga T.

Birth Defects Res A Clin Mol Teratol. 2008 Feb;82(2):106-9.

PMID:
18050337
28.

Reduction in neural-tube defects after folic acid fortification in Canada.

De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee NS, Niyonsenga T.

N Engl J Med. 2007 Jul 12;357(2):135-42.

29.

Fetal sex determination and disclosure.

Van den Hof MC, Demancziuk N; MEMBERS OF THE DIAGNOSTIC IMAGING COMMITTEE.

J Obstet Gynaecol Can. 2007 Apr;29(4):368. doi: 10.1016/S1701-2163(16)32446-X. English, French. No abstract available.

PMID:
17475132
30.

Non-medical use of fetal ultrasound.

Van den Hof MC, Bly S; MEMBERS OF THE DIAGNOSTIC IMAGING COMMITTEE.

J Obstet Gynaecol Can. 2007 Apr;29(4):364-365. doi: 10.1016/S1701-2163(16)32445-8. English, French. No abstract available.

PMID:
17475131
31.

SOGC clinical practice guidelines. Ultrasound evaluation of first trimester pregnancy complications. Number 161, June 2005.

Morin L, Van den Hof MC; Society of Obstetricians and Gynaecologists of Canada.

Int J Gynaecol Obstet. 2006 Apr;93(1):77-81. Review.

PMID:
16724399
33.

Fetal soft markers in obstetric ultrasound.

Van den Hof MC, Wilson RD; Diagnostic Imaging Committee, Society of Obstetricians and Gynaecologists of Canada; Genetics Committee, Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2005 Jun;27(6):592-636. English, French.

PMID:
16100637
34.

Ultrasound evaluation of first trimester pregnancy complications.

Morin L, Van den Hof MC; Diagnostic Imaging Committee, Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2005 Jun;27(6):581-91. English, French.

PMID:
16100636
35.

Obstetric ultrasound biological effects and safety.

Bly S, Van den Hof MC; Diagnostic Imaging Committee, Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2005 Jun;27(6):572-80. English, French.

PMID:
16100635
36.

Obstetric ultrasound: is it time for informed consent?

Van den Hof M, Wilson RD.

J Obstet Gynaecol Can. 2005 Jun;27(6):569-71. English, French. No abstract available.

PMID:
16100634
37.

Changes in maternal characteristics in Nova Scotia, Canada from 1988 to 2001.

Fell DB, Joseph KS, Dodds L, Allen AC, Jangaard K, Van den Hof M.

Can J Public Health. 2005 May-Jun;96(3):234-8. Erratum in: Can J Public Health. 2005 Jul-Aug;96(4):258.

PMID:
15913093
38.

The use of first trimester ultrasound.

Demianczuk NN, Van Den Hof MC, Farquharson D, Lewthwaite B, Gagnon R, Morin L, Salem S, Skoll A; Diagnostic Imaging Committee of the Executive and Council of the Society of Obstetricians and Gynecologists of Canada.

J Obstet Gynaecol Can. 2003 Oct;25(10):864-75.

PMID:
14532956
39.

Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.

Chandra S, Scott H, Dodds L, Watts C, Blight C, Van Den Hof M.

Am J Obstet Gynecol. 2003 Sep;189(3):775-81.

PMID:
14526312
40.

The use of fetal Doppler in obstetrics.

Gagnon R, Van den Hof M; Diagnostic Imaging Committee, Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2003 Jul;25(7):601-14; quiz 615-6. English, French.

PMID:
12851673
41.

Knowledge and attitudes of pregnant women with regard to collection, testing and banking of cord blood stem cells.

Fernandez CV, Gordon K, Van den Hof M, Taweel S, Baylis F.

CMAJ. 2003 Mar 18;168(6):695-8.

42.

Folic acid fortification: time for a concentrated effort.

Van Den Hof MC, Persad VL.

CMAJ. 2002 Oct 15;167(8):848-849. No abstract available.

43.

Incidence of open neural tube defects in Nova Scotia after folic acid fortification.

Persad VL, Van den Hof MC, Dubé JM, Zimmer P.

CMAJ. 2002 Aug 6;167(3):241-5.

44.

Maternal complications with placenta previa.

Crane JM, Van den Hof MC, Dodds L, Armson BA, Liston R.

Am J Perinatol. 2000;17(2):101-5.

PMID:
11023169
45.

Neonatal outcomes with placenta previa.

Crane JM, van den Hof MC, Dodds L, Armson BA, Liston R.

Obstet Gynecol. 1999 Apr;93(4):541-4.

PMID:
10214830
46.

Semi-Fowler's positioning, lateral tilts, and their effects on nonstress tests.

Moffatt FW, van den Hof M.

J Obstet Gynecol Neonatal Nurs. 1997 Sep-Oct;26(5):551-7.

PMID:
9313185
47.

Transvaginal ultrasound in the prediction of preterm delivery: singleton and twin gestations.

Crane JM, Van den Hof M, Armson BA, Liston R.

Obstet Gynecol. 1997 Sep;90(3):357-63.

PMID:
9277644
48.

What has happened to Prägnanz? Coding, stability, or resonance.

van Leeuwen C, van den Hof M.

Percept Psychophys. 1991 Nov;50(5):435-48.

PMID:
1788032
49.

Uterine artery Doppler in the investigation of pregnancies with raised maternal serum alpha-fetoprotein.

Aristidou A, Van den Hof MC, Campbell S, Nicolaides K.

Br J Obstet Gynaecol. 1990 May;97(5):431-5.

PMID:
1695525
50.

Platelet count in normal, small, and anemic fetuses.

Van den Hof MC, Nicolaides KH.

Am J Obstet Gynecol. 1990 Mar;162(3):735-9.

PMID:
2107744

Supplemental Content

Loading ...
Support Center